BioSpace News Archive

Policy

California Life Sciences Association Commends New Legislation to Suspend Medical Device Tax

California Life Sciences Association applauded the introduction of H.R. 4617, which suspends until December 2022 the job and innovation destroying 2.3% medical device excise tax levied on medical device firms originally established as part of the Affordable Care Act.

December 12, 2017

·

2 min read

Genetown

bluebird bio Announces Pricing of 3,243,244 Shares of Public Offering of Common Stock

bluebird bio announced the pricing of an underwritten public offering of 3,243,244 shares of its common stock at a public offering price of $185 per share, before underwriting discounts.

December 12, 2017

·

6 min read

Drug Development

Preliminary Data From Servier and Pfizer’s UCART19 Product Candidate Shows High Complete Remission Rate Across Two Phase I Adult and Pediatric Acute Lymphoblastic Leukemia Trials

These first-in-human data demonstrated the safety and tolerability of UCART19, resulting in an 83% complete remission rate across the adult and pediatric patient population.

December 12, 2017

·

9 min read

Genetown

Editas Medicine Reports Data Supporting Multiple Approaches to Create Treatments for Sickle Cell Disease and Beta-Thalassemia

Experiments support opportunities to develop best-in-class therapies for hemoglobinopathies.

December 12, 2017

·

3 min read

Drug Development

Cynata Release: Final Preclinical Asthma Study Confirms Efficacy

Cynata Therapeuticsis pleased to announce that it has received the final report on the effects of Cymerus MSCs in combination with or in comparison to the corticosteroid dexamethasone in a further preclinical asthma study.

December 12, 2017

·

3 min read

Dana-Farber Cancer Institute Joins the Parker Inst

Deals

NuVasive to Acquire SafePassage for Undisclosed Sum

With the addition of SafePassage, NCS solidifies its leadership position as the largest provider of outsourced IONM services.

December 12, 2017

·

5 min read

Business

IQVIA and Pierre Fabre Pharmaceuticals Expand Relationship to Deploy IQVIA’s Orchestrated Customer Engagement

Under the terms of this seven-year agreement, Pierre Fabre Pharmaceuticals will migrate all of its current CRM users to OCE, which Pierre Fabre Pharmaceuticals selected because of its strong “platform of platforms” foundation and open architecture.

December 12, 2017

·

5 min read

Business

Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration With Major Cancer Center in HER2-Mutated Cancer

Daiichi Sankyo and Puma Biotechnology will co-sponsor the research.

December 12, 2017

·

12 min read

Paradigm Diagnostics Announces Fusion Panel Addition to PCDx

All PCDx tests ordered for patients with lung cancer now also include 17 fusions, as well as EGFR and MET skipping events.

December 12, 2017

·

2 min read

Genetown

Blueprint Medicines, Corp. Announces Pricing of Public Offering of Shares of Common Stock

Blueprint Medicines today announced the pricing of an underwritten public offering of 3,703,704 shares of its common stock at a public offering price of $81.00 per share, before underwriting discounts and commissions.

December 12, 2017

·

4 min read